http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c80a55b58acc843d27dc27c1c732295
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Hoelzer |
| name | Dieter. Hoelzer Dieter Hoelzer |
| given-name | Dieter. Dieter |
| organization-name | Department of Hematology/Oncology, University Medical Center, Frankfurt/Main, Germany From the University of Ulm, Ulm, Germany; the University of Frankfurt, Frankfurt, Germany; La Fe Hospital, Valencia, Spain; the University of Vienna, Vienna, Austria; Manchester Royal Infirmary, Manchester, UK; the University of Rome, Rome, Italy; the University of Gent, Ghent, Belgium; Royal Melbourne Hospital, Melbourne, Australia; and Amgen Ltd, Cambridge, UK. Department of Hematology and Oncology, Johann Wolfgang Goethe University, Frankfurt/Main, Germany; Goethe University Hospital, Frankfurt, Germany. Department of Hematology and Oncology, Johann Wolfgang Goethe University, Frankfurt, Germany; University of Frankfurt Medical Center, Frankfurt, Germany From the Medical Clinic II, University of Kiel, Germany; Institute of Human Genetics, University of Heidelberg, Germany; Medical Clinic II, Department of Hematology, University of Frankfurt, Germany; and Medical Clinic III, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Germany. Goethe University, Germany Department of Internal Medicine III, University of Frankfurt, Frankfurt; Onkologikum Frankfurt/Main Germany Second Medical Department, University Hospital, Frankfurt, Germany; Med. Klinik III, Johann Wolfgang Goethe-Universitäarsklinik, Frankfurt/Main Departments of Pathology and Internal Medicine, Division of Hematology. University of Frankfurt, Germany. From the Division of Hematology/Oncology, Cedars Sinai Research Institute, Los Angeles, CA, and the Department of Pathology, University of California at Los Angeles School of Medicine; Research Service, Veterans Affairs San Diego Healthcare System (VASDHS), CA, and Division of Hematology/Oncology and Cancer Center, University of California at San Diego School of Medicine, La Jolla; and the Department of Hematology/Oncology, University Hospital, Frankfurt/Main, Germany. 1Division of Hematology, Department of Internal Medicine II, Johann Wolfgang Goethe University, Frankfurt, Germany and Goethe University Hospital, Frankfurt, Germany Department of Hematology, University of Frankfurt, Germany. Onkologikum, Frankfurt, Germany Ulrich Dührsen, Stefan Müller, Jan Dürig, Johannes Matschke, Christine Schmitz, Thorsten Pöppel, Andreas Bockisch, and Andreas Hüttmann, Universitätsklinikum Essen; Claudia Ose, Marcus Brinkmann, Karl-Heinz Jöckel, André Scherag, and Jan Rekowski, Universität Duisburg-Essen, Essen; Bernd Hertenstein and Henrike Thomssen, Klinikum Bremen Mitte; Christiane Franzius, Zentrum für moderne Diagnostik, Bremen; Jörg Kotzerke and Frank Kroschinsky, Universitätsklinikum Carl Gustav Carus; Gabriele Prange-Krex,... From Cedars-Sinai Medical Center, Burns and Allen Research Institute, Division of Hematology/Oncology, University of California–Los Angeles School of Medicine; Division of Hematology and Clinical Laboratories, Keio University School of Medicine, Tokyo, Japan; and Department of Hematology, University Hospital, Frankfurt am Main, Germany. Department of Hematology/Oncology and Infectious Diseases, J.W. Goethe-University Hospital, Frankfurt/Main, Germany. Medizinische Klinik II, Johann Wolfgang Goethe Universitätsklinikum, Frankfurt am Main, Germany; Department of Internal Medicine II, Hematology and Oncology, University Hospital, Frankfurt, Germany; Medical Clinic III Hematology/Oncology Department of Internal Medicine University Hospital J.-W. Goethe University Frankfurt/Main Frankfurt, Germany Felicitas Thol, Frederik Damm, Andrea Lüdeking, Claudia Winschel, Katharina Wagner, Michael Morgan, Haiyang Yun, Gudrun Göhring, Brigitte Schlegelberger, Gerhard Heil, Jürgen Krauter, Arnold Ganser, and Michael Heuser, Hannover Medical School; Hartmut Kirchner, Krankenhaus Siloah, Hannover; Dieter Hoelzer, University of Frankfurt, Frankfurt; Michael Lübbert, University of Freiburg Medical Center, Freiburg; Lothar Kanz, University of Tübingen, Tübingen; Walter Fiedler, Hubertus Wald University Cancer... University of Frankfurt, Frankfurt, Germany *Department of Hematology/Oncology, University of Frankfurt Medical Center, Frankfurt am Main, Germany; and Correspondence: Stefan A. Klein, Johann Wolfgang Goethe-Universität, Med Klinik III, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany; e-mail: Department of Hematology, University Hospital, Frankfurt, Germany 1Department of Hematology, Johann Wolfgang Goethe-Universität, Frankfurt, Germany; Department of Internal Medicine, J. W. Goethe University Hospital, Frankfurt, Germany. Center for Internal Medicine, Department of Hematology/Oncology, Johann Wolfgang Goethe University, Frankfurt/Main; Department of Medicine, University Hospital, Frankfurt A.M, Germany Department of Haematology, Johann Wolfsang Goethe Universiry Hospital, Theodor-Stem-Kai, 7, 60596, Frankfurt, Main, Germany Onkologikum, Frankfurt am Museumsufer Frankfurt Germany From the Hôpital Edouard Herriot, Lyon, France; University of Frankfurt, Frankfurt, Germany; Manchester Royal Infirmary, Manchester, UK; University of Vienna, Vienna, Austria; Hôpital Saint-Louis, Paris, France; Hospital Universitario Le Fe, Valencia, Spain; Hannover Medical School, Hannover, Germany; CHU Lille, France; University of Tübingen, Tübingen, Germany; and Amgen Ltd, Cambridge, UK. Department of Hematology, Johann Wolfgang Goethe University Hospital, 60590 Frankfurt/Main, Germany Max S. Topp, Mariele Goebeler, Hermann Einsele, and Ralf C. Bargou, Comprehensive Cancer Center Mainfranken, University Wuerzburg, Wuerzburg; Peter Kufer, Matthias Klinger, Evelyn Degenhard, Dirk Nagorsen, Margit Schmidt, Ralf Lutterbuese, Carsten Reinhardt, Patrick A. Baeuerle, and Gerhard Zugmaier, Micromet AG; Rudolf Köhne-Volland, Metronomia GmbH; Gert Riethmüller, University Munich, Munich; Nicola Gökbuget, Oliver Ottmann, Heike Pfeifer, and Dieter Hoelzer, Goethe-University Frankfurt, Frankfurt;... Department of Medicine II, Hematology/Oncology, Goethe University Hospital, Frankfurt, Germany; From the Department of Molecular Cardiology and Department of Cardiology, Internal Medicine IV, (B.A., V.S., C.T., M.B., R.L., A.A., C.U.), Department of Nuclear Medicine (N.D., F.G.), and the Department of Hematology (H.M., D.H.), University of Frankfurt, Frankfurt, Germany. From ONKOLOGIKUM, Frankfurt, Germany. Third Medical Department, Division of Hematology and Oncology, Johann Wolfgang Goethe University, Frankfurt/Main, Germany Goethe University Hospital, Department of Medicine II, Hematology/Oncology, Frankfurt am Main, Germany From the Charité Universitätsmedizin Berlin, Medizinische Klinik III, Berlin; Johann Wolfgang Goethe-Universität, Medizinische Klinik III, Frankfurt/Main; Max Planck-Institut für Molekulare Genetik, Berlin; and Institut für Humangenetik und Anthropologie, Heinrich-Heine-Universität, Düsseldorf, Germany. em. University of Frankfurt, Frankfurt, Germany Goethe-Universität, Medizinische Klinik II, Frankfurt, Germany From the Med. Klinik III/Abtl. Hämatologie, Johann Wolfgang Goethe-Universität, Frankfurt, Germany; Dipartimento di Istologia ed Embriologia Medica, Università “La Sapienza,” Rome, Italy; and the Institute of Cell Biology and Tissue Engineering, San Raffaele Bio-medical Science Park of Rome, Rome, Italy. From the Department of Hematology, University Hospital, Frankfurt/Main, Germany; the Division of Hematology/Oncology, Cedars Sinai Research Institute, University of California Los Angeles (UCLA) School of Medicine, CA; and Novartis Pharma AG, Nuremberg, Germany From the Departments of Hematology and Oncology and Biostatistics and Clinical Epidemiology, Charité, University Hospital Berlin, Campus Benjamin Franklin, Berlin; Department of Hematology and Oncology, University of Frankfurt am Main, Frankfurt/Main, Germany; and The Ohio State University Comprehensive Cancer Center, Columbus, OH Author affiliations appear at the end of this article. From the Department of Hematology, Oncology, and Transfusion Medicine; Department of Biostatistics and Clinical Epidemiology, Charité, Campus Benjamin Franklin Berlin, University Hospital, Berlin; Department of Hematology and Oncology, University of Frankfurt am Main, Frankfurt, Germany; and Ohio State University, Comprehensive Cancer Center, Columbus, OH Department of Hematology, Johann Wolfgang Goethe University Hospital, Frankfurt/Main, Germany Department of Hematology, Johann Wolfgang Goethe University, Frankfurt, Germany; From the Department of Hematology and Oncology, University Medical Center, Tübingen, Germany; and Department of Hematology and Oncology, University Medical Center, Frankfurt/Main, Germany. Goethe University Hospital, Department of Medicine II, Hematology/Oncology, Frankfurt/M., Germany From the Medical Clinic III, Department of Hematology, University of Frankfurt, Germany; the Department of Lymphoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; the Department of Hematology, University of Freiburg, Germany; and the Department of Hematology, General Hospital St Georg, Hamburg, Germany. Department of Hematology/Oncology and Infectious Diseases, J. W. Goethe-University Hospital, Frankfurt/Main, Germany. From the Division of Hematology/Oncology, Cedars Sinai Research Institute, and Department of Pathology, UCLA School of Medicine, Los Angeles, California; Department of Hematology, University Hospital, Frankfurt am Main, Germany; Novartis Pharma AG, Nürnberg, Germany. Department of Pathology, University Hospital Frankfurt, Germany Max S. Topp, Hermann Einsele, and Ralf C. Bargou, Universitätsklinikum Würzburg, Würzburg; Nicola Gökbuget, Goethe University; Dieter Hoelzer, Onkologikum, Frankfurt; Gerhard Zugmaier, Petra Klappers, and Noemi Mergen, Amgen Research; Dorothea Wessiepe, Metronomia, Munich; Matthias Stelljes, University of Münster, Münster; Svenja Neumann, Heinz-August Horst, and Monika Brüggemann, University Schleswig Holstein, City Hospital, Kiel; Andreas Viardot, University of Ulm, Ulm; Reinhard Marks,... Department of Medicine II, Hematology/Oncology, Goethe University Hospital, Frankfurt/Main, Germany; From the Departments of Hematology/Oncology of the University Hospitals Frankfurt, Hannover, Dresden, Münster, Ulm, Heidelberg, Munich; the Deutsche Klinik für Diagnostik, Wiesbaden; the Klinik für Knochenmarktransplantation, Idar-Oberstein; Krankenanstalt Mutterhaus der Borromäerinnen, Trier; and Novartis Pharma AG, Nürnberg, Germany. From the Clinic for Bone Marrow Transplantation and Hematology/Oncology, Idar-Oberstein; German Clinic for Diagnostics, Wiesbaden; Medizinische Hochschule, Hannover; University Hospital Eppendorf, Hamburg; Westfaelische Wilhelms University, Muenster; Carl Gustav Carus University, Dresden; University Hospital, Frankfurt; University Hospital, Cologne, Germany; Center for Allogeneic Stem Cell Transplantation, Huddinge, Sweden Department of Hematology and Oncology, University Hospital, Frankfurt, Germany Med. Klinik III/Abtl. Hämatologie, Johann Wolfgang Goethe-Universität, D-60590 Frankfurt, Germany From the Med. Klinik II, Johann Wolfgang Goethe-Universitätsklinik, Frankfurt/Main; II. Med. Klinik, Krankenhaus Nordwest, Frankfurt/Main; St.-Marienkrankenhaus, Hamm; Medizinische Hochschule, Hannover; Städtische Kliniken, Darmstadt; Onkologische Schwerpunktpraxen in Aschaffenburg, Wiesbaden, Krefeld, Cottbus, Germany From the University of Frankfurt, Frankfurt, Germany. Department of Hematology and Oncology, Goethe University, Frankfurt, Germany From the Molecular Virology Lab, Georg-Speyer-Haus, Frankfurt, Germany; the Department of Hematology/Oncology, Bone Marrow Transplantation Hospital, Idar-Oberstein, Germany; the Molecular Immunology Unit, Institute of Child Health, London, UK; and the Department of Hematology/Oncology, School of Medicine, University of Frankfurt, Frankfurt, Germany. From the Medical Clinic III, Hematology/Oncology, J.W. Goethe University, Frankfurt, Germany. From Ospedali Riuniti, Bergamo, Italy; and the Klinikum der Goethe-Universität, Medizinische Klinik II, Frankfurt, Germany. Medizinische Klinik II, Johann Wolfgang Goethe-Universität, Frankfurt/Main; Medizinische Klinik II/Abteilung Hämatologie, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt, Germany From the Medizinische Klinik III, Abteilung für Hämatologie und Onkologie of the Johann Wolfgang Goethe-Universität, Frankfurt, Germany; Red Cross Blood Donation Service, Oldenburg, Germany; and Novartis Pharma AG, Nürnberg, Germany. J.W. Goethe University Hospital Frankfurt Germany Department of Medicine II, Department of Hematology/Oncology, University Hospital, Frankfurt, Germany From the Department of Hematology/Oncology of the University Hospitals Frankfurt, Munich, Dresden, Heidelberg, and Münster, Germany; the Department of Cytogenetics, University of Marburg, Germany; Robert Bosch Klinik Stuttgart, Germany; Deutsche Klinik für Diagnostik Wiesbaden, Germany; Hospital Munich-Schwabing, Germany; and Novartis Pharma AG, Nürnberg, Germany. |
Incoming Links
Total number of triples: 372.